Skip to content

The application of Presepsin to evaluate the curative effect and prognosis of sepsis

The application of Presepsin to evaluate the curative effect and prognosis of sepsis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039152
Enrollment
Unknown
Registered
2020-10-20
Start date
2020-10-19
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SEPSIS

Interventions

Gold Standard:Clinical outcome
Index test:The&#32
and&#32
evaluation&#32
model&#32
for&#32
sepsis.

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Exclusion criteria

Exclusion criteria: 1. Clinical results missing; 2. Critical information missing; 3. From the medical point of view, it is necessary to terminate clinical trial.

Design outcomes

Primary

MeasureTime frame
clinical score (SOFA, APECHE II);

Secondary

MeasureTime frame
survival rate;

Countries

China

Contacts

Public ContactYing Li

Shenzhen Second People's Hospital

yeyu2007@qq.com+86 18924678391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026